REFERENCES
- Piketty C, Weiss L, Thomas F, Mohamed AS, Belec L, Kazatchkine MD. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibi-tor-containing regimen. J Infect Dis. 2001;183:1328–1335.
- Meyers R, Szuch W, Nerurkar V, Alexander S, Patel J, Joseph J. The impact of HIV-1 diversity in Maryland: under quantifying "non-B" subtype HIV-1 viral loads with the FDA approved assay. In: Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections, January 30-February 2, 2000; San Francisco CA. Abstract 173.
- Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV viral subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses. 1999;15:133–142.
- Guidelines for the use of antiretroviral agents in HIV in-fected adults and adolescents. February 5, 2001. Available at: www.hivatis.org
- Walter EA, Gilliam B, Delmar JA, et al. Clinical implications of identifying non-B subtypes of human immunodeficiency vi-rus type 1 infection. Clin Infect Dis. 2002;31(3):798–802.
- Zapiola I, Fernandez Giuliano S, Wainstein C, et al. Misquantification of plasma HIV-RNA subtype F among clinical samples from Argentina. In: Program and abstracts of the XIIIth International AIDS Conference; July 9–14, 2000. Durban, South Africa. Abstract M0PeA2128.
- Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the Amplicor HIV-1 Monitor test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin MicrobioL 1999;37:110–116.
- Elbeik T, Alvord WG, Trichavaroj R, et al. Comparative analy-sis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor Version 1.5. JAIDS. 2002;29:330–339.
- Balotta C, Facchi G, Violin M, et al. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and pro-tease sequences. JAIDS. 200127: 499–505.
- Russell KL, Carcamo A, Watts, DM, et al. Emerging genetic diversity of HIV-1 in South America. AIDS. 2000;1:1785–1791.
- Fonjungo PN, Mpoudi EN, Torimiro JN, et al. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res Hum Retroviruses. 2000;16:1319–1324.
- Holguin A, Rodes B, Soriano V, Gonsalez-Lahoz J. Recom-binant HIV-1 variants circulating in Spain. In: Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco CA. Abstract 175.
- Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after six months of highly active antiretroviral therapy. Ann Intern Med. 2000;133:401–410.
- Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis. 2000;181:946–953.
- Kaufmann D, Pantaleo G, Sudre P, Telenti A. CD4 cell count in HIV-1 infected individuals remaining viraemic with highly active antiretrovirals. Lancet. 1998;351:723–724.
- Beatrice ST, Collie M, El-Fishawy M, Oleszko WR. Detection of large numbers of HIV-1 group M non-B subtypes in New York City. In: Program and abstracts of the Seventh Confer-ence on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco CA. Abstract 171.
- Zaid I, Weinstock H, Parekh B, et al. Surveillance of HIV-1 subtypes in the United States, 1998-present. In: Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco CA. Abstract 215.
- Womack C, Roth W, Newman C, et al. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. J Infect Dis. 2001183: 138–142.
- Dwyer DE, Herring B, Wang AL, et al. Multiple HIV-1 sub-types circulating in Australia. In: Program and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco CA. Abstract 177.